NEW YORK (GenomeWeb) – Genomic data firm PierianDx today announced it is exclusively licensing a proprietary genetic testing tool and processes from Washington University in St. Louis.

PierianDx will offer the tool, called the Clinical Genomicist Workstation, to other clinical labs "giving them an end-to-end solution for managing clinical next-generation sequencing processes." CGW is a software platform for NGS clinical tests that manages data and workflow, the St. Louis-based company said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.